The Protein Interaction Between Interleukin-6 and APOBEC3 Provides Insight into Liver Cancer Treatment
Liver cancer is the second most common cause of cancer related death worldwide, and hepatocellular carcinoma (HCC) accounts for more than 90% of those cases. HCC is the sixth most common type of cancer in the world, the fifth most common in males (7.5%)
